Post-earnings recap
Reported
Thu, Apr 26, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bristol Myers Squibb's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 1.55%. This drop may reflect investor concerns over the lack of revenue data and future guidance, which could impact confidence in the company's growth prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.64 | N/A | +5.09% |
Management expressed satisfaction with the EPS results, highlighting the company's commitment to its product pipeline. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering value through our pipeline.